NCT04958590 is a clinical trial of whole spine X-ray in Sagittal Alignment, sponsored by Peking University Third Hospital.

Who is sponsoring NCT04958590?

NCT04958590 is sponsored by Peking University Third Hospital.

What drugs are being tested in NCT04958590?

Interventions in NCT04958590: whole spine X-ray.

What condition does NCT04958590 study?

NCT04958590 studies Sagittal Alignment.

Is NCT04958590 still recruiting?

NCT04958590 is currently completed. Last updated 12 July 2021.

Last reviewed 2021-07-12 · How we verify

NCT04958590

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Standing and Sitting Spino-pelvic Sagittal Alignment in Chinese Population

Completed Last updated 12 July 2021

What this trial tests

trial testing whole spine X-ray in Sagittal Alignment in 216 participants. Completed in 1 March 2020.

Timeline

20 February 2019

Primary endpoint
9 September 2019

1 March 2020

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	216
Start date	20 February 2019
Primary completion	9 September 2019
Estimated completion	1 March 2020
Sites	1 location across China

Drugs / interventions tested

whole spine X-ray

Conditions studied

Sagittal Alignment — all drugs for Sagittal Alignment →

Sponsor

Peking University Third Hospital

Who can join

Adults 42 to 85, any sex, with Sagittal Alignment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed to demonstrate the standing and sitting spino-pelvic sagittal alignment in Chinese population, then to explore the influence of spinal fusion on the changes when moving from standing to sitting positon.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04958590 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 12 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04958590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing